anonymous
Guest
anonymous
Guest
I'm glad I stumbled across this thread. I just started getting into the neurostim market - looking for job opportunities. Third quarter results show that MDT leads the market based on global sales, followed by BSC and then ABT, with Nevro catching up every quarter. Last I checked, Nevro had half the quarterly sales of ABT, so seems to be a legitimate player with a $6B dollar market cap. Are these the 4 main players?